Aspen Pharmacare Holdings (APN.JO) Stock Price
Aspen Pharmacare Holdings Price
Over the last 19 years Aspen Pharmacare Holdings grew revenue by 12.0% annually, reaching 34.87 B ZAR. Earnings per share have grown at 6.1% per year over the last 19 years. For Aspen Pharmacare Holdings, the net margin of 7.6% is down versus 16.8% a few years ago. At today's price the dividend yield works out to roughly 1.28%. The payout ratio is around 28% of earnings. The dividend has grown at 6.1% per year over the past 19 years. The consensus 12-month price target for Aspen Pharmacare Holdings is 117.30 ZAR, about 28.7% below where the stock trades today. Of 10 analysts, 0 rate the stock a buy — an overall Hold consensus.
Aspen Pharmacare Holdings stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aspen Pharmacare Holdings business model & stock analysis
Frequently asked questions about Aspen Pharmacare Holdings
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analysts currently set an average price target of 120.02 ZAR for the Aspen Pharmacare Holdings stock (median: 117.30 ZAR), implying -27.0 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Aspen Pharmacare Holdings stock: 0 recommend buying, 6 holding and 4 selling.
Converted at the current exchange rate, the Aspen Pharmacare Holdings share trades at 8.84 EUR (164.45 ZAR).
The Aspen Pharmacare Holdings share (APN.JO) is listed on 5 stock exchanges, including: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
The revenue of Aspen Pharmacare Holdings is 34.87 B ZAR. This figure is based on current financial data and reflects the company's business performance.
The profit of Aspen Pharmacare Holdings is 2.65 B ZAR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Aspen Pharmacare Holdings is currently 27.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Aspen Pharmacare Holdings stock.
The price-to-sales ratio (P/S) of Aspen Pharmacare Holdings is currently 2.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Aspen Pharmacare Holdings stock.
The Eulerpool Quality Score for Aspen Pharmacare Holdings is 1/10.
The ISIN of Aspen Pharmacare Holdings is ZAE000066692. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Aspen Pharmacare Holdings is A0ET80. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Aspen Pharmacare Holdings is APN.JO. The ticker symbol is used to trade Aspen Pharmacare Holdings shares on the stock exchange.
Aspen Pharmacare Holdings stock
Aspen Pharmacare Holdings Peer Group
Aspen Pharmacare Holdings Ticker
Aspen Pharmacare Holdings FIGI
All fundamentals and in-depth analysis of Aspen Pharmacare Holdings
Our stock analysis for Aspen Pharmacare Holdings stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspen Pharmacare Holdings. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.